Clinical outcomes for nasopharyngeal cancer with intracranial extension after taxane‐based induction chemotherapy and concurrent chemo‐radiotherapy in the modern era
Sarbani Ghosh‐Laskar(Tata Memorial Hospital), Anil D’Cruz(Tata Memorial Hospital), Anuja Deshmukh(Tata Memorial Hospital), Tejpal Gupta(Tata Memorial Hospital), Vijay Patil(Homi Bhabha National Institute), Jai Prakash Agarwal(Tata Memorial Hospital), Vanita Noronha, Monali Swain(Tata Memorial Hospital), Deepa Nair(Homi Bhabha National Institute), Carlton Johnny(Homi Bhabha National Institute), Vedang Murthy(Homi Bhabha National Institute), Pankaj Chaturvedi(Tata Memorial Hospital), Amit Joshi(Dr. Rajendra Prasad Government Medical College), Gouri Pantvaidya(Tata Memorial Hospital), Devendra Chaukar(Tata Memorial Hospital), Sudhir Nair(Homi Bhabha National Institute), Kumar Prabhash(Homi Bhabha National Institute), Ashwini Budrukkar(Tata Memorial Hospital), Avinash Pilar(Tata Memorial Hospital), Shivakumar Thiagarajan(Tata Memorial Hospital), Prathamesh Pai(Tata Memorial Hospital)
World Journal of Otorhinolaryngology - Head and Neck Surgery
March 1, 2020
Cited by 3
Related Papers
The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694
Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017
|European Urology|2017|644
Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019
|European Urology|2020|396
Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis
|European Journal of Nuclear Medicine and Molecular Imaging|2011|377
Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial
|Journal of Clinical Oncology|2017|340